2017-11-15T16:20:13-06:00 2016-12-31 910189318 Moss Adams LLP 4747 Executive Drive Suite 1300 San Diego CA 92121 990 2016-01-01 473355381 Parker Institute for Cancer Immunotherapy PARK 4159304386 1 Letterman Drive D3500 San Francisco CA 94129 Jeffrey A Bluestone President & CEO 4159304386 2017-11-15 1 Patricia J Mayer P00188643 8586271400 12.129.7.100 2017-11-15 16:15:00 PS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 82B2967E87B0BCBFD086468C9F628B4E32DA0AA9 2016 2021-01-29 14:40:06Z X Jeffrey A Bluestone 1 Letterman Drive D3500 San Francisco CA 94129 39900210 0 X www.parkerici.org X 2015 CA The Parker Institute for Cancer Immunotherapy (PICI) was created to encourage advances in cancer immunotherapy research and to help reduce obstacles to collaboration, discovery and translation of these advances for patients. The Institute achieves this goal by funding a consortium of preeminent academic and medical research institutions which work collaboratively on research in the field of cancer immunotherapy. In addition, PICI furthers its charitable purposes by employing its own personnel to directly assist these institutions in their research and clinical trials. 4 4 35 6 0 0 74021413 39828555 0 0 -518694 41843 7045 29812 73509764 39900210 64000000 22174378 0 0 1545875 6810019 0 0 0 3661244 10120472 69207119 39104869 4302645 795341 5207689 6100956 578427 676353 4629262 5424603 TO ENABLE REAL COLLABORATION, ACCELERATING THE MOST AMBITIOUS RESEARCH TO DELIVER NEW IMMUNOTHERAPIES ENGINEERED TO SAVE LIVES. 0 0 35414193 22174378 The Parker Institute for Cancer Immunotherapy encourages advances in cancer immunotherapy research to help reduce obstacles to collaboration, discovery and translation of these advances for patients. The Institute funds a consortium of preeminent academic and medical research institutions which work collaboratively on research in the field of cancer immunology. 35414193 1 1 0 0 0 0 0 0 0 0 1 0 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 1 0 0 0 0 0 1 0 0 0 1 37 0 1 35 1 0 0 0 0 0 0 0 0 0 0 X 4 4 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X Parker Institute for Cancer Immunotherapy 4159857311 1 Letterman Drive Suite D3500 San Francisco CA 94129 Sean N Parker Chair of the Board and Dir 1.00 X X 0 0 0 MICHAEL POLANSKY VICE PRESIDENT & DIRECTOR 1.00 X X 0 0 0 Laurie Glimcher Director 1.00 X 0 0 0 TOM VAN LOBEN SELS SECRETARY/Treasurer & DIr 1.00 X X 0 0 0 JEFFREY A BLUESTONE PRESIDENT AND CEO 40.00 X 775000 90000 134406 Adam M Kolom VP-Business Development 30.00 X 559000 0 51084 SUSAN SCHULTZ VP-BUSINESS OPERATIONS 40.00 X 261028 0 25714 RAMY IBRAHIM VP-CLINICAL RESEARCH & DEV 40.00 X 547601 0 111154 NIKESH KOTECHA VP-IMFORMATICS 40.00 X 401240 0 39287 MELINDA GRIFFITH CHIEF LEGAL COUNSEL, VP-STRATEGIC 40.00 X 357800 0 42786 Susanne Hildebrand-Zanki DIrector-special projects 40.00 X 184258 0 17114 FRED RAMSDELL VP-RESEARCH 32.00 X 187526 0 34691 DAVID HOFFMAN EXECUTIVE DIRECTOR-INTELLECTUAL PROPERTY 40.00 X 294220 0 20094 Cheryl L Selinsky PhD VP-Research Operations 40.00 X 366500 0 35808 JENNIFER HASLIP VP-COMMUNICATIONS 40.00 X 287347 0 34084 LETICIA LICEA HR & OFFICE MANAGER 40.00 X 134994 0 33281 EHUD GOLD EXECUTIVE DIRECTOR-TECHNOLOGY 40.00 X 126109 0 27259 4482623 90000 606762 13 0 1 0 INdx Technology Inc 20380 Towne Center Lane Suite 218 Cupertino CA 95014 Clinical Development Services 990773 Inventiv Health Clinical LLC PO BOX 415914 Boston MA 02241 Clinical Development Services 487562 Linle J Froeb Events LLC 191 Stanyan Street San Francisco CA 94118 Event Services 329728 Connery Consulting 135 Ward Street Larkspur CA 94939 HR CONSULTING SERVICES 222700 Arnold & Porter LLP 601 MASSACHUSETTS AVENUE NW WASHINGTON DC 20001 Legal Services 189620 11 2200000 37628555 39828555 41843 41843 Settlement Proceeds 900099 29812 29812 29812 39900210 0 0 71655 22174378 22174378 4767742 3670329 1097413 1469699 1042824 426875 140675 94252 46423 166321 110919 55402 265582 191713 73869 276066 220853 55213 194072 194072 3392317 2874080 518237 5497 5452 45 300500 172319 128181 615007 526354 88653 1175748 587874 587874 626489 498579 127910 1015361 933820 81541 133553 133553 16036 16036 Equipment 2277774 2253606 24168 Telecommunications 61905 29334 32571 Dues & Membership 30147 27507 2640 39104869 35414193 3690676 0 592138 1360050 1635874 2139634 1323346 9932 380 1199990 1010989 84161 1124411 134287 308793 990124 326617 326617 5207689 6100956 578427 676353 578427 676353 X 2979299 5097986 1649963 326617 4629262 5424603 5207689 6100956 795341 0 X 0 1 X 1 0 X 74021413 39828555 113849968 74021413 39828555 113849968 71663847 42186121 10489 41843 52332 7045 29812 36857 113939157 X Schedule A, Part II, Line 10, Explanation of Other Income: Settlement proceeds - 2015 Amount: $ 7,045. 2016 Amount: $ 29,812. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 636483 636483 487928 134287 353641 990124 LEASE GUARANTEE 326617 326617 X 52723302 12823092 12823092 39900210 0 39900210 51927961 12823092 12823092 39104869 0 39104869 Part X, Line 2: THE ORGANIZATION HAS NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES AS OF DECEMBER 31, 2016 AND DECEMBER 31, 2015. 1 MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVE BOX 69 NEW YORK NY 10065 912154267 501(c)(3) 117185 Support research in field of cancer immunotherapy Stanford University 3145 Porter Drive Palo Alto CA 94304 941156365 501(c)(3) 11132430 Support research in field of cancer immunotherapy University of California Los Angeles 10920 Wilshire Blvd Ste 620 Los Angeles CA 90024 956006143 govt 7000000 Support research in field of cancer immunotherapy Washington University 700 Rosedale Avenue CB 1034 Saint Louis MO 63112 430653611 501(c)(3) 500000 Support research in field of cancer immunotherapy Icahn School of Medicine One Gustave L Levy Place New York NY 10029 136171197 501(c)(3) 2000000 Support research in field of cancer immunotherapy Regents of University of California San Francisco 333 CALIFORNIA ST 315 San Francisco CA 94143 946036493 GOVT 294400 Support research in field of cancer immunotherapy The Jackson Laboratory 600 Main Street Bar Harbor ME 04609 010211513 501(c)(3) 176217 Support research in field of cancer immunotherapy University of Pennsylvania 3451 Walnut Street Philadelphia PA 19104 231352685 GOVT 196400 Support research in field of cancer immunotherapy UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1400 PRESSLER STREET FCT295223 HOUSTON TX 77030 746001118 govt 687746 Support research in field of cancer immunotherapy SAGE BIONETWORKS 1100 FAIRVIEW AVE N SEATTLE WA 98109 264489946 501(c)(3) 70000 Support research in field of cancer immunotherapy 10 0 Part I, Line 2: the organization awards grants subject to a master collaboration agreement and a specific grant agreement applicable to each institution. X 1 1 X X 0 0 0 0 0 0 0 1 0 JEFFREY A BLUESTONE PRESIDENT AND CEO 650000 90000 125000 0 0 0 42950 0 91456 0 909406 90000 0 0 Adam M Kolom VP-Business Development 400000 0 159000 0 0 0 0 0 51084 0 610084 0 0 0 SUSAN SCHULTZ VP-BUSINESS OPERATIONS 247810 0 13218 0 0 0 3750 0 21964 0 286742 0 0 0 RAMY IBRAHIM VP-CLINICAL RESEARCH & DEV 270704 0 276897 0 0 0 8250 0 102904 0 658755 0 0 0 NIKESH KOTECHA VP-IMFORMATICS 342045 0 59195 0 0 0 7950 0 31337 0 440527 0 0 0 MELINDA GRIFFITH CHIEF LEGAL COUNSEL, VP-STRATEGIC 302133 0 55667 0 0 0 7950 0 34836 0 400586 0 0 0 Susanne Hildebrand-Zanki DIrector-special projects 167552 0 16706 0 0 0 12329 0 4785 0 201372 0 0 0 FRED RAMSDELL VP-RESEARCH 170526 0 17000 0 0 0 4901 0 29790 0 222217 0 0 0 DAVID HOFFMAN EXECUTIVE DIRECTOR-INTELLECTUAL PROP 258406 0 35814 0 0 0 7707 0 12387 0 314314 0 0 0 Cheryl L Selinsky PhD VP-Research Operations 335000 0 31500 0 0 0 9294 0 26514 0 402308 0 0 0 JENNIFER HASLIP VP-COMMUNICATIONS 229167 0 58180 0 0 0 0 0 34084 0 321431 0 0 0 LETICIA LICEA HR & OFFICE MANAGER 122754 0 12240 0 0 0 4529 0 28752 0 168275 0 0 0 EHUD GOLD EXECUTIVE DIRECTOR-TECHNOLOGY 114615 0 11494 0 0 0 3138 0 24121 0 153368 0 0 0 Part I, Line 3 The Board of Directors reviews any proposed compensation the salary of its Chief Executive Officer to ensure that, in each case, it is such salary is fair and reasonable based on comparability data showing compensation paid for comparable services at similarly situated organizations. Part I, Line 7 DISCRETIONARY BONUSES ARE AWARDED BASED ON PERFORMANCE. Nikesh Kotecha Key Employee RESIDENCE ASSISTANCE X 500000 499990 0 1 1 Ramy Ibrahim Key Employee RELOCATION X 700000 700000 0 1 1 1199990 Sean N Parker Foundation Common control 330000 LEASE GUARANTEE 0 APERCEN PARTNERS LLC TOM VAN LOBEN SELS, OFFICER & BOARD MEMBER OF PICI IS A > 35% OWNER OF LLC 134309 Professional Services 0 Form 990, Part VI, Section A, line 2 Tom van Loben Sels and Sean Parker have a business relationship. Tom van Loben Sels and Michael Polansky have a business relationship. Michael Polansky is an employee of an entity owned by Sean Parker. Form 990, Part VI, Section B, line 11b THE FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE. A COMPLETE COPY OF THE FORM 990 AND SUPPORTING SCHEDULES WAS PROVIDED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED. Form 990, Part VI, Section B, line 12c The Board authorizes and oversees a review of the admnistration of the conflict of interest policy. The review considers the level of compliance with the policy, the continuing suitability of the policy, and whether the policy should be modified and improved. IF A TRANSACTION ARISES WHERE THERE IS A CONFLICT OF INTEREST, THE PERSON WITH SUCH CONFLICT IS NOT ALLOWED TO VOTE ON THE TRANSACTION. Form 990, Part VI, Section B, line 15 FORM 990, PART VI, SECTION B, LINE 15A - As stated at Schedule J, Part I, Line 3, the Board of Directors approved the salary of the organization's Chief Executive Officer only after having confirmed it is fair and reasonable based on comparability data showing compensation paid for comparable services at similarly situated organizations. These procedures were followed when the Chief Executive Officer's salary was approved by the Board of Directors, which does not include the Chief Executive Officer, on October 10, 2015. Specifically, the Board of Directors relied on a compensation survey provided by Sullivan, Cotter, and Associates, Inc. Any future changes to the compensation (including any bonuses paid) of the Chief Executive Officer will only be approved by the Board of Directors after following the procedures described above. FORM 990, PART VI, SECTION B, LINE 15B - In general, PICI worked with Connery Consulting in recruiting and, as part of that process, routinely compared the proposed salary with salaries paid by other organizations for similar positions. Form 990, Part VI, Section C, line 19 THE ORGANIZATIONS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AS REQUIRED BY LAW. Sean N Parker Foundation 314 LYTTON AVENUE SUITE 200 PALO ALTO CA 94301 274389819 SUPPORTS NONPROFIT ORGANIZATIONS CA 501(C)(3) PF N/A 0 ECONOMIC INNOVATION GROUP INC 616 H STREET NW SUITE 550 WASHINGTON DC 20001 462450336 PUBLIC INTEREST ADVOCACY DC 501(C)(4) N/A N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SEAN N PARKER FOUNDATION C 2200000 FMV